3Dimensions System User Guide
Chapter 1: Introduction
MAN-05085-002 Revision 002
Page 1
DRAFT
Preview Copy-Generated May 30, 2018
1:
Introduction
Read all this information carefully before operating the system. Follow all warnings and
precautions as stated in this manual. Keep this manual available during procedures.
Physicians should tell patients about all potential risks and adverse events described in
this manual with respect to the operation of the system.
Note
Hologic configures some systems to meet specific requirements. Your system
configuration may not have all the options and accessories included in this manual.
1.1
Intended Use
Caution: Federal law restricts this device to sale by or on the order of a physician.
The Hologic
®
3Dimensions™ system is indicated to generate digital mammographic
images that can be used for screening and diagnosis of breast cancer. The 3Dimensions
(2D or 3D) system is intended for use in the same clinical applications as a 2D
mammography system for screening mammograms. Specifically, the 3Dimensions
system can be used to generate 2D digital mammograms and 3D mammograms. Each
screening examination may consist of:
•
a 2D FFDM image set
- OR -
•
a 2D and 3D image set, where the 2D image can be either an FFDM or a 2D
image generated from the 3D image set
The 3Dimensions system may also be used for additional diagnostic workup of the
breast.
Note
In Canada and Singapore, Tomosynthesis is not approved for screening, and must be
used in conjunction with a 2D image (either a FFDM image or 2D image generated from
the 3D image set).
Contrast Enhanced Digital Mammography
Contrast Enhanced Digital Mammography (CEDM) is an extension of the existing
indication for diagnostic mammography with the 3Dimensions system. The CEDM
application shall enable contrast enhanced breast imaging using a dual energy technique.
This imaging technique can be used as an adjunct following mammography and/or
ultrasound exams to localize a known or suspected lesion.
1.1.1
Contraindications
There are no known contraindications.
Chapter 1